Brief: SK Biopharmaceuticals Says To Acquire 177 Billion Won Worth Of Shares In Ignis Therapeutics
11/11/2021 01:46
Nov 11 (Reuters) -
* SK BIOPHARMACEUTICALS: TO ACQUIRE 177 BILLION WON WORTH OF
SHARES IN IGNIS THERAPEUTICS
Further company coverage: 326030.KS
(Reporting by Joyce Lee)
((JungYoon.Lee@thomsonreuters.com;))
Recent news on SK Biopharmaceuticals
See all newsBrief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
US FDA pauses new enrollment in Biohaven's epilepsy drug trials (updated)
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million
U.S. STOCKS ON THE MOVE-Meta, Kohl's, J.M. Smucker